62-76-0
62-76-0
Chemical Structure
Sodium oxalate,99.5%
Synonym(s): Ethanedioic acid sodium
- CAS No.: 62-76-0
- Formula:NaOOCCOONa
- Molecular Weight:134.00
IUPAC Name: sodium oxalate
InChIKey: ZNCPFRVNHGOPAG-UHFFFAOYSA-L
SMILES: O=C(O[Na])C(O[Na])=O
Biological Activity: Sodium oxalate is an orally active dispersant and coordination agent. Sodium oxalate causes mitochondrial dysfunction. Sodium oxalate has catalytic enhancing activity. Sodium oxalate induces stable chronic kidney disease. Sodium oxalate induces highly malignant and undifferentiated breast tumors[1][2][3][4][5][6][7][8].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Sodium oxalate,99.5% | 99.65% | Sodium oxalate is an orally active dispersant and coordination agent. Sodium oxalate causes mitochondrial dysfunction. Sodium oxalate has catalytic enhancing activity. Sodium oxalate induces stable chronic kidney disease. Sodium oxalate induces highly malignant and undifferentiated breast tumors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Disodium succinate (Standard) | 99.99% | Disodium succinate (Standard) is the analytical standard of Disodium succinate. This product is intended for research and analytical applications. Disodium succinate is an anti-anxiety agent with oral activity. Disodium succinate is the salt form of Succinic acid. Disodium succinate is an intermediate product of the tricarboxylic acid cycle. Disodium succinate is an important platform chemical. Disodium succinate can be used as surfactant, additive, ion chelating agent, flavoring agent and other applications in chemical, pharmaceutical and food fields. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Disodium succinate-13C2 | 99.3% | Disodium succinate-13C2 is the 13C-labeled Disodium succinate Succinic acid is an anti-anxiety agent with oral activity. Disodium succinate is the salt form of Succinic acid. Succinic acid is an intermediate product of the tricarboxylic acid cycle. Succinic acid is an important platform chemical. Succinic acid can be used as surfactant, additive, ion chelating agent, flavoring agent and other applications in chemical, pharmaceutical and food fields. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fumaric acid disodium | 99.98% | Fumaric acid disodium is an unsaturated dicarbonic acid, an intermediate product of the citric acid cycle that provides intracellular energy in the form of ATP. Fumaric acid disodium exerts anti-inflammatory effects by inhibiting the NF-κB signaling pathway dependent on p38 MAPK. Fumaric acid disodium can be used in the study of pregnancy-induced hypertension. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fumaric acid2,3-13C2 disodium | 99% | Fumaric acid2,3-13C2 disodium is the 13C-labeled Fumaric acid (disodium) (HY-W015883A). Fumaric acid disodium is an unsaturated dicarbonic acid, an intermediate product of the citric acid cycle that provides intracellular energy in the form of ATP. Fumaric acid disodium exerts anti-inflammatory effects by inhibiting the NF-κB signaling pathway dependent on p38 MAPK. Fumaric acid disodium can be used in the study of pregnancy-induced hypertension. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid sodium | 99.86% | Pyruvic acid sodium is an intermediate metabolite in the metabolism of carbohydrates, proteins, and fats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-13C3 sodium | 99.61% | Sodium 2-oxopropanoate-13C3 is the 13C-labeled Sodium 2-oxopropanoate. Sodium 2-oxopropanoate (Sodium pyruvate), a three-carbon metabolite of Glucose, is a compound produced in the glycolytic pathway. Sodium 2-oxopropanoate is a free radical scavenger that can scavenge ROS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-13C-1 sodium | 98.90% | Sodium 2-oxopropanoate-13C is the 13C labeled Sodium 2-oxopropanoate. Sodium 2-oxopropanoate (Sodium pyruvate), a three-carbon metabolite of Glucose, is a compound produced in the glycolytic pathway. Sodium 2-oxopropanoate is a free radical scavenger that can scavenge ROS. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oxalic Acid-13C2 disodium | 98.15% | Oxalic Acid-13C2 (disodium) is the 13C labeled Oxalic Acid disodium. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pyruvic acid-13C sodium | 99.18% | Pyruvic acid-13C (sodium) is the 13C-labeled Pyruvic acid. Pyruvic acid is an intermediate metabolite in the metabolism of carbohydrates, proteins, and fats. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Bai Z, et al. Electrooxidation of formic acid catalyzed by Pd Nanoparticles supported on multi-walled carbon nanotubes with sodium oxalate. Ionics, 2013, 19(3): 543-548.
- [2]. Knoll T, et al. The influence of oxalate on renal epithelial and interstitial cells. Urol Res. 2004 Aug;32(4):304-9. [Content Brief]
- [3]. Patel M, et al. Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. Redox Biol. 2018 May;15:207-215. [Content Brief]
- [4]. Castellaro AM, et al. Oxalate induces breast cancer. BMC Cancer. 2015 Oct 22;15:761. [Content Brief]
- [5]. Heller A, et al. Oxalic acid has an additional, detoxifying function in Sclerotinia sclerotiorum pathogenesis. PLoS One. 2013 Aug 12;8(8):e72292. [Content Brief]
- [6]. Flora SJ, et al. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats. Arch Toxicol. 2002 Jun;76(5-6):269-76. [Content Brief]
- [7]. Mulay SR, et al. Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice. Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F785-F795. [Content Brief]
- [8]. Kamil M A, et al. Pharmacological evaluation of aqueous extract of plant formulation against sodium oxalate induced urolithiasis in mice[J]. Int J Original Res, 2016, 2(2): 32-39.
